COIMMUNE INC has a total of 29 patent applications. It increased the IP activity by 150.0%. Its first patent ever was published in 2001. It filed its patents most often in Australia, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ARGOS THERAPEUTICS INC, ONCOLYS BIOPHARMA INC and CENTELION.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 16 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Canada | 3 | |
#4 | Republic of Korea | 3 | |
#5 | Norway | 1 | |
#6 | United States | 1 | |
#7 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Chemical engineering | |
#5 | Medical technology | |
#6 | Environmental technology | |
#7 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Nicolette Charles | 12 |
#2 | Horvatinovich Joseph | 10 |
#3 | Debenedette Mark | 10 |
#4 | Monesmith Tamara | 8 |
#5 | Paul Sudhir | 5 |
#6 | Hanson Carl Veith | 5 |
#7 | Nishiyama Yasuhiro | 5 |
#8 | Dusek Alex | 5 |
#9 | Tcherepanova Irina | 5 |
#10 | Weksler Marc | 5 |
Publication | Filing date | Title |
---|---|---|
KR20210015873A | Method for producing natural killer cells and uses thereof | |
AU2018366011A1 | Methods and uses for dendritic cell therapy | |
AU2013215525A1 | Centrifuge vessels suitable for live cell processing and associated systems and methods | |
AU2012203683A1 | Catalytic immunoglobulins | |
AU2009245792A1 | Humanized antibodies against human interferon-alpha | |
WO2007011639A2 | Catalytic immunoglobulins |